Inactive Instrument

All News Yumanity Therapeutics

Equities

YMTX

US98872L1026

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

Yumanity Therapeutics : Dosed First Patient in Phase 1/2 Clinical Study of VISTA-Targeting KVA12123 in Advanced Solid Tumors Initial KVA12123 Clinical Data Readout Anticipated by End of 2023 Closed $6 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - Form 8-K	23-05-11	PU
Yumanity Therapeutics : Regulation FD Presentation - Form 8-K	23-04-17	PU
Yumanity Therapeutics : VISTA blocking immunotherapy engineered to address immunosuppression in the tumor microenvironment (TME) Phase 1 initial data readout anticipated by end of 2023 - Form 8-K	23-04-12	PU
Yumanity Therapeutics : January 2023 Developing next-generation immunotherapies that address cancer immune resistance KA (Nasdaq) - Form 8-K	23-01-05	PU
Yumanity Therapeutics : Kineta Completes Reverse Merger with Yumanity Therapeutics - Form 8-K	22-12-22	PU
Kineta's Shares Gain Momentum on Nasdaq Debut Following Yumanity Therapeutics Reverse Merger Completion	22-12-19	MT
Kineta, Yumanity Therapeutics Complete Reverse Merger	22-12-19	MT
YUMANITY THERAPEUTICS, INC. Other Events (form 8-K/A)	22-12-16	AQ
Yumanity Therapeutics Inc.(NasdaqCM:KA) dropped from NASDAQ Composite Index	22-12-16	CI
Kineta, Inc. completed the acquisition of Yumanity Therapeutics, Inc. from a group of shareholders in a reverse merger transaction.	22-12-15	CI
Yumanity Therapeutics : Acquisition/Asset Disposal - Form 8-K	22-12-15	PU
YUMANITY THERAPEUTICS, INC. : Completion of Acquisition or Disposition of Assets, Other Events, Financial Statements and Exhibits (form 8-K)	22-12-15	AQ
Sector Update: Health Care Stocks Stage Small Recovery Late	22-12-14	MT
Sector Update: Health Care	22-12-14	MT
Top Midday Decliners	22-12-14	MT
Stocks Remain Relatively Flat as Investors Wait for Fed Rate-Hike Move	22-12-14	MT
Investors Remain Sidelined in Premarket Trading Ahead of Fed Decision Wednesday	22-12-14	MT
Top Premarket Decliners	22-12-14	MT
YUMANITY THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)	22-12-13	AQ
YUMANITY THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	22-12-06	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Yumanity Therapeutics

Equities

YMTX

US98872L1026

All News

Filters